Focus Groups to Determine Surrogates Views Regarding Patient Preference Predictors
NCT ID: NCT02898194
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2018-12-31
2020-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some people cannot make medical treatment decisions on their own. The people who make decisions on their behalf are called medical surrogates. Sometimes surrogates cannot predict which treatment course the person or their loved ones would have chosen. The surrogates often become distressed because of making these decisions. Researchers think a tool called a Patient Preference Predictor (PPP) may be able to make the process easier. The PPP would predict what treatment the person would want. This is based on treatment preferences of similar people in a similar circumstance. Researchers want to interview surrogates to explore their views on the PPP.
Objective:
To explore surrogates views on incorporating a PPP into shared medical decision-making.
Eligibility:
People 18 years or older who:
Have acted as a surrogate medical decision-maker within the past 3 years. This includes decisions about
treatment, medication, hospice care, hospital admission, or discharge.
Are not pregnant
Design:
Participants will be screened by meeting with clinicians in person or by phone to discuss the study.
Participants will take part in a focus group. This is a small group of people discussing their thoughts and opinions. This will last for about 2 hours.
Participants will be served a light meal.
Participants will provide information about themselves and their views. They will talk about their past experiences making medical decisions for someone. They will discuss how they felt about these decisions.
The PPP will be explained to participants. They will give their views on it.
The research team will audio record the focus group and take notes.
Participants will fill out questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research Participants Perceptions of Their Experience in Clinical Studies
NCT00729534
Research Participant Perception of Care Project: Part II: Fielding and Validation of the Research Participant Perception Survey Derived From Focus Group-Identified Key Dimensions of the Research Participant Experience
NCT01129869
Achieving Patient-Centered Care and Optimized Health In Care Transitions by Evaluating the Value of Evidence
NCT02354482
An Interactive Patient-Centered Consent for Research Using Medical Records
NCT03063268
Testing a Video Decision Support Tool to Supplement Goals-of-Care Discussions
NCT01391429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1/Patient Surrogates
Any eligible participant who have acted as a surrogate medical decision-maker.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experience making at least one medical decision on behalf of an incompetent patient within the past 3 years. A medical decision for the purposes of this study is defined as making a decision in a context in which there was more than 1 feasible or reasonable option.
* Ability to provide informed consent
Exclusion Criteria
* The patient on behalf of whom the individual acted as surrogate is deceased for less than two months.
* In the view of the referring clinician, participation in the study is deemed excessively burdensome.
* Candidate for study is pregnant
* Court appointed surrogate
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health Clinical Center (CC)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Wendler, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Institutes of Health Clinical Center (CC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Elizabeths Hospital
Washington D.C., District of Columbia, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shalowitz DI, Garrett-Mayer E, Wendler D. How should treatment decisions be made for incapacitated patients, and why? PLoS Med. 2007 Mar;4(3):e35. doi: 10.1371/journal.pmed.0040035. No abstract available.
Rid A, Wendler D. Use of a patient preference predictor to help make medical decisions for incapacitated patients. J Med Philos. 2014 Apr;39(2):104-29. doi: 10.1093/jmp/jhu001. Epub 2014 Feb 13.
Rid A, Wesley R, Pavlick M, Maynard S, Roth K, Wendler D. Patients' priorities for treatment decision making during periods of incapacity: quantitative survey. Palliat Support Care. 2015 Oct;13(5):1165-83. doi: 10.1017/S1478951514001096. Epub 2014 Oct 2.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-CC-0168
Identifier Type: -
Identifier Source: secondary_id
160168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.